For SCFA profiling, samples were spiked with 5 nmol of 13C-sodium acetate (279293, SIGMA) and 5 nmol of 2-ethyl butyric acid (109959, SIGMA) as internal standards and were homogenised in isopropanol. After centrifugation, 1 μL of the supernatant was injected into a HP 6890 Series GC System, equipped with an Agilent 5973 Network Mass Selective Detector in splitless mode. Samples were separated on a Stabilwax®-DA (Shimadzu) column (30 m × 0.25 mm i.d.) coated with a 0.25-μm-thick film. The carrier gas was helium at a flow rate of 1 mL min−1. The initial oven temperature of 90 °C was held for 2 min, then increased to 240 °C at 5 °C min−1 and maintained for additional 2 min. The temperature of the quadrupole, MS source and inlet were 150, 230 and 250 °C, respectively. Identities and retention times of the SCFA were established using the volatile-free acid mix (46975-U, Supelco). Peaks were automatically integrated using MSD ChemStation (version D.03.00.611). SCFA concentration was estimated using the internal references 13C-sodium acetate (for acetic acid) or 2-ethyl butyric acid (for all the others SCFA tested). Data were calculated as nanomoles per microlitre serum or per milligram caecal content from at least three biological replicates within each different group.
Butyric Acid
It is a colorless, oily liquid with a unpleasant, rancid odor.
Butyric acid is naturally produced during the fermentation of carbohydrates and is found in butter, cheese, and other dairy products.
It plays a role in various physiological processes and has been studied for its potential therapeutic applications, including as a treatment for gastrointestinal disorders and cancer.
Researchers utilize a variety of experimental protocols to investigate the properties and effects of butyric acid, which can be optimized using tools like PubCompare.ai to identify the most reproducible and accurate methods from the scientific literature.
Most cited protocols related to «Butyric Acid»
For SCFA profiling, samples were spiked with 5 nmol of 13C-sodium acetate (279293, SIGMA) and 5 nmol of 2-ethyl butyric acid (109959, SIGMA) as internal standards and were homogenised in isopropanol. After centrifugation, 1 μL of the supernatant was injected into a HP 6890 Series GC System, equipped with an Agilent 5973 Network Mass Selective Detector in splitless mode. Samples were separated on a Stabilwax®-DA (Shimadzu) column (30 m × 0.25 mm i.d.) coated with a 0.25-μm-thick film. The carrier gas was helium at a flow rate of 1 mL min−1. The initial oven temperature of 90 °C was held for 2 min, then increased to 240 °C at 5 °C min−1 and maintained for additional 2 min. The temperature of the quadrupole, MS source and inlet were 150, 230 and 250 °C, respectively. Identities and retention times of the SCFA were established using the volatile-free acid mix (46975-U, Supelco). Peaks were automatically integrated using MSD ChemStation (version D.03.00.611). SCFA concentration was estimated using the internal references 13C-sodium acetate (for acetic acid) or 2-ethyl butyric acid (for all the others SCFA tested). Data were calculated as nanomoles per microlitre serum or per milligram caecal content from at least three biological replicates within each different group.
To generate MdHY5 transgenic apple calli, the recombinant plasmid was introduced into Agrobacterium tumefaciens LBA4404 as described by An et al.36 (link) Regarding the transformation of apple calli, 15-day-old ‘Orin’ calli (WT) were co-cultured with Agrobacterium carrying MdHY5-pCAMBIA1300. The calli were co-cultured on MS medium containing 1.5 mg L−1 2, 4-dichlorophenoxyacetic acid and 0.5 mg L−1 6-butyric acid for 2 days at room temperature. The calli were then washed three times with sterile water and transferred to selective media supplemented with 300 mg L−1 carbenicillin and 35 mg L−1 hygromycin for transgene selection. The transgenic apple calli were co-cultivated in selective media that contained appropriate concentrations of antibiotics.
Most recents protocols related to «Butyric Acid»
Example 133
Step 1: tert-butyl (2S)-2-(3-cyano-3-hydroxypropyl)pyrrolidine-1-carboxylate. To a solution of tert-butyl (S)-2-(3-oxopropyl)pyrrolidine-1-carboxylate (114 mg, 0.5 mmol) in DCM (1 mL) was added Et3N (0.1 mL) and acetone cyanohydrin (0.1 mL, 1.2 mmol). The mixture was stirred at r.t. over night. The solution was concentrated by vacuum and purified by silica gel column to afford the title product (120 mg) as colorless oil. MS: [M+1]+ 255.
Step 2: 2-hydroxy-4-((S)-pyrrolidin-2-yl)butanoic acid. To a solution of tert-butyl (2S)-2-(3-cyano-3-hydroxypropyl)pyrrolidine-1-carboxylate (60 mg, 0.23 mmol) in dioxane (0.8 mL) was added HCl (con., 0.8 mL). The mixture was stirred at 100° C. overnight. After cooling to r.t., dioxane was removed by evaporation. The residue was washed by EtOAc (0.5 mL×2). The aqueous phase was collected and evaporated to give a crude product which was used directly in the next step without purification. MS: [M+1]+ 174.
Step 3: 4-((S)-1-(7,8-dichloro-4-(1H-imidazol-1-yl)quinolin-2-yl)pyrrolidin-2-yl)-2-hydroxybutanoic acid (I-817). The title compound was prepared essentially by the same methods as for I-664. MS: [M+1]+ 435.
Example 124
HATU (39.9 g, 105 mmol) was added to a solution of 4-(((benzyloxy)carbonyl)amino) butanoic acid (26.1 g, 110 mmol) in DMF (300 mL). After stirring at r.t. for 30 min, the mixture was added to a solution of compound 110 (39.4 g, 100 mmol) and TEA (20.2 g, 200 mmol) in DMF (300 mL). The resulting mixture was stirred at r.t. for 2 h. Water was then added, extracted with EtOAc, the organic layer was washed with brine, dried over Na2SO4. Purification by column chromatography (20% to 70% EA/PE) yielded the title product as a white solid (45 g, 73% yield). ESI m/z calcd for C33H48N3O8 [M+H]+: 614.34, found 614.15.
Example 12
-
- A composition comprising:
- about 0.01% to 3.0% of a plurality of functionalized metallic nanofibers, substantially all of the metallic nanofibers having at least a partial coating of a polyvinyl pyrrolidone polymer;
- a first solvent comprising about 2.5% to 8% 1-butanol, ethanol, 1-pentanol, n-methylpyrrolidone, or 1-hexanol, or mixtures thereof;
- a second solvent comprising about 0.01% to 5% of an acid or bases, including organic acids such as carboxylic acids, dicarboxylic acids, tricarboxylic acids, alkyl carboxylic acids, acetic acid, oxalic acid, mellitic acid, formic acid, chloroacetic acid, benzoic acid, trifluoroacetic acid, propanoic acid, butanoic acid, or bases such as ammonium hydroxide, sodium hydroxide, potassium hydroxide, or mixtures thereof;
- a viscosity modifier, resin, or binder comprising about 1.0% to 4.5% PVP, polyvinyl alcohol, or a polyimide, or mixtures thereof; and
- with the balance comprising a third solvent such as cyclohexanol, cyclohexanone, cyclopentanone, cyclopentanol, butyl lactone, or mixtures thereof.
Example 80
DMAP (0.8 g, 6.56 mmol) and DCC (17.1 g, 83 mmol) were added to a solution of 4-(((benzyloxy)carbonyl)amino)butanoic acid (16.4 g, 69.2 mmol) and t-BuOH (15.4 g, 208 mmol) in DCM (100 mL). After stirring at r.t. overnight, the reaction was filtered and filtrate concentrated. The residue was dissolved in ethyl acetate and the washed with 1N HCl, brine and dried over Na2SO4. Concentration and purification by column chromatography (10 to 50% EtOAc/hexanes) yielded compound 427 (7.5 g, 37% yield). MS ESI m/z calcd for C16H23NO4Na [M+Na]+ 316.16, found 316.13.